Activation of the TGF-β1/Smad signaling by KIF2C contributes to the malignant phenotype of thyroid carcinoma cells
- 25 September 2021
- journal article
- research article
- Published by Elsevier BV in Tissue and Cell
- Vol. 73, 101655
- https://doi.org/10.1016/j.tice.2021.101655
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81901774)
This publication has 28 references indexed in Scilit:
- Distinct Diagnostic and Prognostic Values of Kinesin Family Member Genes Expression in Patients with Breast CancerMedical Science Monitor, 2018
- New insights into TGF-β/Smad signaling in tissue fibrosisChemico-Biological Interactions, 2018
- Transforming Growth Factor-β1/Smad7 in Intestinal Immunity, Inflammation, and CancerFrontiers in Immunology, 2018
- Glyoxalase 1 sustains the metastatic phenotype of prostate cancer cells via EMT controlJournal of Cellular and Molecular Medicine, 2018
- CD151 promotes cell metastasis via activating TGF-β1/Smad signaling in renal cell carcinomaOncotarget, 2018
- Special types of thyroid carcinomaHistopathology, 2017
- The thyroid cancer epidemic, 2017 perspectiveCurrent Opinion in Endocrinology, Diabetes and Obesity, 2017
- Transforming growth factor-β1 signaling promotes epithelial-mesenchymal transition-like phenomena, cell motility, and cell invasion in synovial sarcoma cellsPLOS ONE, 2017
- Kinesin superfamily protein expression and its association with progression and prognosis in hepatocellular carcinomaJournal of Cancer Research and Therapeutics, 2017
- NY‐CO‐58/KIF2C is overexpressed in a variety of solid tumors and induces frequent T cell responses in patients with colorectal cancerInternational Journal of Cancer, 2009